Diversified Trust Co Sells 308 Shares of The Cigna Group (NYSE:CI)

Diversified Trust Co reduced its stake in shares of The Cigna Group (NYSE:CI) by 9.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,983 shares of the health services provider’s stock after selling 308 shares during the quarter. Diversified Trust Co’s holdings in The Cigna Group were worth $1,083,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CI. Aviance Capital Partners LLC grew its holdings in The Cigna Group by 3.2% in the first quarter. Aviance Capital Partners LLC now owns 17,868 shares of the health services provider’s stock worth $6,489,000 after purchasing an additional 550 shares during the last quarter. MorganRosel Wealth Management LLC purchased a new stake in The Cigna Group in the first quarter valued at about $214,000. Breakwater Capital Group raised its stake in The Cigna Group by 3.4% in the first quarter. Breakwater Capital Group now owns 1,183 shares of the health services provider’s stock valued at $430,000 after buying an additional 39 shares during the last quarter. Optas LLC grew its stake in shares of The Cigna Group by 1.7% during the first quarter. Optas LLC now owns 5,022 shares of the health services provider’s stock worth $1,824,000 after acquiring an additional 86 shares during the last quarter. Finally, Red Door Wealth Management LLC increased its holdings in shares of The Cigna Group by 3.1% during the first quarter. Red Door Wealth Management LLC now owns 3,435 shares of the health services provider’s stock valued at $1,248,000 after acquiring an additional 102 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their target price on shares of The Cigna Group from $432.00 to $435.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 12th. Baird R W raised The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. Barclays assumed coverage on The Cigna Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price target for the company. Finally, Oppenheimer increased their price objective on The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $376.20.

The Cigna Group Trading Down 1.3 %

CI stock opened at $326.27 on Tuesday. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $365.71. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.75. The firm has a market cap of $92.68 billion, a P/E ratio of 26.79, a PEG ratio of 1.01 and a beta of 0.52. The company’s 50-day simple moving average is $341.23 and its 200-day simple moving average is $333.41.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The company had revenue of $57.25 billion for the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The Cigna Group’s revenue for the quarter was up 23.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.41 earnings per share. As a group, equities analysts forecast that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th were given a $1.40 dividend. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.72%. The Cigna Group’s dividend payout ratio (DPR) is 45.98%.

Insider Transactions at The Cigna Group

In other news, insider Brian C. Evanko sold 4,795 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the transaction, the insider now owns 39,923 shares in the company, valued at $13,773,834.23. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other The Cigna Group news, Director Elder Granger sold 547 shares of the stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the sale, the director now owns 5,471 shares in the company, valued at approximately $1,812,979.98. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 4,795 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the transaction, the insider now owns 39,923 shares in the company, valued at $13,773,834.23. The disclosure for this sale can be found here. Insiders sold 22,988 shares of company stock valued at $7,975,726 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.